(ID: 284) Age-related changes in serotonin and lower bowel dysfunction: potential future preventative strategies
International Journal of Pharmacy Practice · 05.11.2026 · 34 (Supplement_2) · ii80-ii81
DOI: 10.1093/ijpp/riag145.105 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmacy Practice, online erschienen am 06.11.2026. Verfasst von Ryan Hopkins und 2 weiteren Autor:innen. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Introduction
Age-related lower bowel dysfunction is a significant clinical and economic challenge, affecting approximately 10% of adults over the age of 60 in the UK and costing the NHS an estimated £1.7 billion annually [1]. Conditions such as chronic constipation and faecal incontinence contribute substantially to reduced quality of life, increased hospital admissions, and long-term care requirements. Current management strategies are largely reactive, focusing on symptom control after dysfunction has developed rather than preventing disease progression. Serotonin (5-hydroxytryptamine; 5-HT), is a key pharmacological mediator of bowel function, released from enterochromaffin cells within the mucosal epithelium. Acting through receptors including 5-HT₃ and 5-HT₄, serotonin initiates and modulates secondary messenger systems and enteric reflexes that regulate propulsion and defecation. Despite its established role throughout the gastrointestinal tract, the effects of ageing on serotonergic signalling and continence have not been fully characterised [2].
Aim
To investigate age-related changes in serotonin and determine the contribution to lower bowel dysfunction.
Method
A longitudinal preclinical study was undertaken in 20 male C57BL/6J mice assessed at 12, 14, 16 and 18 months of age to investigate age-related changes in lower bowel serotonin availability. Serotonin was measured in vivo using 3D-printed electrochemical sensors, with electrochemical techniques used to quantify serotonin release. Measures of bowel function, including faecal pellet output and faecal water content, were assessed alongside serotonin signalling to evaluate age-associated functional changes. All procedures complied with the UK Animals (Scientific Procedures) Act 1986 and were conducted under Home Office project licence PP1472338.
Results
Anodic peak current increased significantly with age, showing an enhanced serotonin availability in older age groups (one-way ANOVA, p < 0.0001, n = 14). In contrast, faecal pellet output and faecal water content decreased with age (one-way ANOVA, p < 0.001, n = 20), indicating the development of an age-associated constipation phenotype. The coexistence of elevated serotonin release and a constipation phenotype suggests that age-related dysfunction may arise from dysregulation of serotonergic signalling pathways.
Discussion
This study demonstrates that ageing is associated with a significant increase in serotonin alongside lower bowel dysfunction. When combined with previous ex vivo pharmacological studies a consistent picture emerges: ageing enhances mucosal transmitter availability but disrupts synchronised motor coordination. Elevated 5-HT appeared linked to altered epithelial handling, including increased synthesis, reduced uptake via the serotonin reuptake transporter (SERT), or impaired clearance. Prolonged 5-HT exposure has previously been shown to desensitise 5-HT₃ receptors on sensory neurons and reduce 5-HT₄ receptor efficacy on motor neurons. This may reflect age-related changes in function of SERT, leading to altered 5-HT3 receptor responsiveness and changes in 5-HT-dependent secondary messenger mechanisms resulting in uncoordinated motility responses [2,3]. Collectively, these findings identify several potential targets for future investigation. Modulation of serotonin clearance pathways, including SERT, and modulation of 5-HT₃- and 5-HT₄-mediated signalling pathways may represent potential strategies for improving gastrointestinal motility in ageing populations. Limitations include the exclusion of female animals due to insufficient data and the use of a preclinical model, requiring validation in human populations. These findings highlight the value of mechanistic pharmacological research in identifying future diagnostic, preventative, and therapeutic strategies. Keywords Ageing, Serotonin (5-HT), Lower bowel dysfunction, Constipation, Gastrointestinal motility, Serotonergic signalling, Electrochemical sensing, Preventative medicine, Pharmacology
Zitieren
APA
Hopkins, R., Patel, B., & Yeoman, M. (2026). (ID: 284) Age-related changes in serotonin and lower bowel dysfunction: potential future preventative strategies. International Journal of Pharmacy Practice, 34(Supplement_2), ii80-ii81. https://doi.org/10.1093/ijpp/riag145.105
Vancouver
Hopkins R, Patel B, Yeoman M. (ID: 284) Age-related changes in serotonin and lower bowel dysfunction: potential future preventative strategies. International Journal of Pharmacy Practice. 2026;34(Supplement_2):ii80-ii81. doi:10.1093/ijpp/riag145.105
BibTeX
@article{Hopkins2026,
author = {Hopkins, Ryan and Patel, Bhavik and Yeoman, Mark},
title = {(ID: 284) Age-related changes in serotonin and lower bowel dysfunction: potential future preventative strategies},
journal = {International Journal of Pharmacy Practice},
year = {2026},
volume = {34},
number = {Supplement_2},
pages = {ii80--ii81},
doi = {10.1093/ijpp/riag145.105}
}
EUVIMED